Medical Action Industries

Medical Action Industries — UBS Global Life Sciences Conference 2012

16 slides from Medical Action Industries's conference presentation, Sep 21, 2012

  1. Slide 1: Medical Action Industries – UBS Global Life Sciences Conference

    Slide 1: Medical Action Industries – UBS Global Life Sciences Conference

    Medical Action INDUSTRIES ING. Medical Action Industries UBS Global Life Sciences Conference September 20, 2012

  2. Slide 2: Looking Statements

    Slide 2: Looking Statements

    Looking Statements Any statement concerning Management'’s expectation with respect to future results is a forward- looking statement based upon reasonable information and assumptions currently available to Management; however Management does not intend the statement to be a representation as to futu

  3. Slide 3: Executive Summary

    Slide 3: Executive Summary

    Executive Summary Introduction to Medical Action Industries © Medical Action is a leading global manufacturer and supplier of high quality single use / disposable medical products ™ Market leadership in key product lines = 35 year reputation for superior value, quality and service ™ Publicly traded

  4. Slide 4: Global Manufacturing

    Slide 4: Global Manufacturing

    Global Manufacturing © Global Manufacturing Operations and Relationships ™ Nearly 750,000 square feet of manufacturing and office facilities = Import approximately $75 million each year Clarksburg, West Virginia Shanghai, China Brentwood, New York Toano, Virginia eee 3

  5. Slide 5: Market Opportunity

    Slide 5: Market Opportunity

    Market Opportunity A large and growing market for medical supplies © Large Addressable Market = $307+ billion global medical device market, going to nearly $350 billion by 2016 * = $105+ billion U.S. medical device market 2 ® $38 billion U.S. disposable medical supplies market, going to over $46 bil

  6. Slide 6: Strategy to Achieve Success

    Slide 6: Strategy to Achieve Success

    Strategy to Achieve Success National Reach to Most Major Facilities * Capitalize on national footprint * Drive penetration of all product lines * Develop more value-added products Improve Outcomes & Lower Costs * Improve clinical outcomes, reduce infection rates and increase comfort * Assist hospita

  7. Slide 7: Business Channels and SBUs

    Slide 7: Business Channels and SBUs

    Business Channels and SBUs To address these strategies, Medical Action has created a more focused organizational structure ® Medical Action operates and reports in one business segment — disposable medical supplies © We disclose net revenue along two primary business channels — Patient Care and Clin

  8. Slide 8: Patient Care

    Slide 8: Patient Care

    Patient Care Patient Bedside Disposables/Reusables Lab Products + Triangular Graduates * Lab Containers Stainless Steel + Tripour beakers Urology Specimen Containers + Commode Collectors * Sterile, Std & Nesting * 24-hour collectors * — Non-Sterile, Std & Nesting * Mid-stream Catch kits Medical Acti

  9. Slide 9: Custom Procedure Trays

    Slide 9: Custom Procedure Trays

    Custom Procedure Trays © Approximately $2 billion U.S. market © 90% of all hospitals use at least one Custom Procedure Tray © 55% of all single-use materials are delivered in a Custom Procedure Tray

  10. Slide 10: Minor Procedure Kits & Trays

    Slide 10: Minor Procedure Kits & Trays

    Minor Procedure Kits & Trays © Provides consistency of quality for nursing care © Improved cost and ease of inventory, stocking and replenishment Central Line Dressing Change Tray General Purpose and Instrument Trays IV Start Kits Laceration Trays ‘Suture Removal Trays PICC / Vascular Access Trays M

  11. Slide 11: Financial Overview

    Slide 11: Financial Overview

    Financial Overview

  12. Slide 12: Financial Overview — Net Sales

    Slide 12: Financial Overview — Net Sales

    Financial Overview — Net Sales Medical Action has a history of solid top line growth performance Net Sales CAGR ('00-'12): 15% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Amounts in $ million; Fiscal Years ended March 31 Medical Action 1"

  13. Slide 13: Financial Overview — Operating Income

    Slide 13: Financial Overview — Operating Income

    Financial Overview — Operating Income Despite strong historic growth in Operating Income, recent cost increases have had an impact Operating Income $35.0 $30.0 PEALE $25.0 CAGR ('00-'10): 15% $20.0 $15.0 $10.0 $5.0 $0.0 r 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Amounts in $

  14. Slide 14: Investment Highlights

    Slide 14: Investment Highlights

    Investment Highlights Industry Dynamics © Significant player in large and growing market ® Aging population © Increased use of disposable medical supplies Corporate Initiatives ® Focus on Improving Core Operations ™ Salesforce effectiveness and discipline ™ Cost and expense management = Production p

  15. Slide 15: Selection of Products

    Slide 15: Selection of Products

    Selection of Products

  16. Slide 16: Medical Action Industries

    Slide 16: Medical Action Industries

    Medical Action INDUSTRIES ING. Medical Action Industries UBS Global Life Sciences Conference September 20, 2012

Source: SEC EDGAR · 8-K filed Sep 21, 2012

More decks from Medical Action Industries